» Articles » PMID: 24337841

Amplification of Functional Myeloid-derived Suppressor Cells During Stem Cell Mobilization Induced by Granulocyte Colony-stimulation-factor

Overview
Specialty General Medicine
Date 2013 Dec 17
PMID 24337841
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of granulocyte colony-stimulation-factor (G-CSF) on stem cell mobilization and its impact on the amplification of myeloid-derived suppressor cells (MDSCs) of donor mice were examined. A mouse model of stem cell mobilization was established by consecutive subcutaneous injection of 100 μg/kg G-CSF for 5 days. The blood from the donor mice was routinely examined during mobilization. Stem cells and MDSCs were analyzed by flow cytometry. The immunosuppressive molecules derived from MDSCs in serum and spleen, including hydrogen dioxide (H2O2) and nitric oxide (NO), and the activity of nitric oxide synthase (NOS) were determined during the mobilization. Apoptosis of T lymphocytes was assessed by using Annexin-V/PI. During stem cell mobilization, the number of lymphocytes and white blood cells in the peripheral blood was increased, and peaked on the 4th day. The number of stem cells in G-CSF-treated mice was significantly greater than that in controls (P<0.01). The expansions of MSDCs were also observed after G-CSF mobilization, with a more notable rate of growth in the peripheral blood than in the spleen. The activity of NOS and the production of NO were increased in the donor mice, and the serum H2O2 levels were approximately 4-fold greater than the controls. Consequently, apoptosis of T lymphocytes was increased and showed a positive correlation with the elevated percentage of MDSCs. It was concluded that G-CSF could provide sufficient peripheral blood stem cells for transplantation. Exogenous administration of G-CSF caused the accumulation of MDSCs in the peripheral blood and the spleen, which could lead to apoptosis of T lymphocytes and may offer a new strategy for the prevention and treatment of graft versus host disease.

Citing Articles

Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Plessis N, Jacobs R, Gutschmidt A, Fang Z, van Helden P, Lutz M Eur J Immunol. 2016; 47(1):107-118.

PMID: 27861788 PMC: 5233566. DOI: 10.1002/eji.201646658.


Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Long X, Wang J, Zhao J, Liang H, Zhu P, Cheng Q J Huazhong Univ Sci Technolog Med Sci. 2016; 36(5):667-676.

PMID: 27752888 DOI: 10.1007/s11596-016-1643-2.

References
1.
Highfill S, Rodriguez P, Zhou Q, Goetz C, Koehn B, Veenstra R . Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010; 116(25):5738-47. PMC: 3031417. DOI: 10.1182/blood-2010-06-287839. View

2.
Arpinati M, Green C, Heimfeld S, Heuser J, Anasetti C . Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2001; 95(8):2484-90. View

3.
Kusmartsev S, Gabrilovich D . Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother. 2005; 55(3):237-45. PMC: 1350971. DOI: 10.1007/s00262-005-0048-z. View

4.
Dugast A, Haudebourg T, Coulon F, Heslan M, Haspot F, Poirier N . Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol. 2008; 180(12):7898-906. DOI: 10.4049/jimmunol.180.12.7898. View

5.
Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S . Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant. 2013; 19(5):692-702. PMC: 4011929. DOI: 10.1016/j.bbmt.2013.01.008. View